Pomalidomide-PEG2-butyl iodide is a high-quality E3 Ligase Ligand-Linker Conjugate designed specifically for PROTAC (Proteolysis Targeting Chimera) research and drug development. This compound features pomalidomide, a well-established ligand for the CRBN (cereblon) E3 ubiquitin ligase, linked via a flexible PEG2 spacer to a butyl iodide functional group, making it ideal for coupling with various target protein ligands. As a PROTAC intermediate, Pomalidomide-PEG2-butyl iodide enables researchers to efficiently design and synthesize bifunctional molecules that harness the cell's ubiquitin-proteasome system for selective protein degradation. Its versatile structure supports the rapid development of next-generation therapeutics targeting disease-related proteins, including those implicated in cancer, neurodegeneration, and other pathologies. This product is an essential tool for medicinal and chemical biology researchers pioneering targeted protein degradation strategies.
Structure of 1835705-72-0
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Pomalidomide-PEG2-butyl iodide is a specialized E3 ligase ligand-linker conjugate designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). Pomalidomide acts as a cereblon (CRBN) E3 ligase ligand, while the PEG2 (polyethylene glycol spacer) and butyl iodide group offer enhanced solubility and chemical versatility for coupling to various target protein ligands. This makes Pomalidomide-PEG2-butyl iodide an optimal choice for researchers seeking to develop next-generation protein degraders.
Mechanism
The mechanism of action of Pomalidomide-PEG2-butyl iodide is rooted in its role as a E3 ligase ligand within bifunctional PROTAC molecules. The pomalidomide moiety selectively binds to the cereblon (CRBN) E3 ubiquitin ligase complex. The PEG2 linker provides spatial flexibility and improved solubility, while the terminal butyl iodide group acts as a reactive handle for chemical conjugation. Upon incorporation into a PROTAC, this conjugate facilitates the recruitment of the E3 ligase to a target protein, leading to polyubiquitination and subsequent proteasomal degradation of the target protein within cells.
Applications
Pomalidomide-PEG2-butyl iodide is widely used as a chemical scaffold in the construction of custom PROTAC molecules. Its applications include the targeted degradation of disease-associated proteins in cancer biology, neurodegenerative disorders, and drug discovery research. This conjugate enables researchers to efficiently design and synthesize protein degraders with tailored selectivity and potency. It is also valuable for generating tool compounds to investigate protein function, validate therapeutic targets, and accelerate the development of novel protein degradation-based drugs.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.